ArticleCancer immunology, immunotherapy : CII2018

Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.

Niken M Mahaweni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.